Organization
Cedars-Sinai Cancer Institute, Los Angeles, CA
2 abstracts
Abstract
Metabolic disorders in patients diagnosed with colorectal cancer.Org: Department of Internal Medicine, Oregon Health & Science University, Portland, OR, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, Department of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Heidelberg, Germany, Fred Hutchinson Cancer Research Center, Seattle, WA, Department of Surgery, The University of Tennessee, Memphis, TN,
Abstract
A phase 1 first-in-human clinical trial of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, in advanced solid tumors.Org: Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, University of Texas Southwestern Medical Center, Dallas, TX, Stanford Cancer Center GI Surgical Oncology, Stanford, CA, Cedars-Sinai Cancer Institute, Los Angeles, CA, Cedars-Sinai Medical Center, Los Angeles, CA,